trending Market Intelligence /marketintelligence/en/news-insights/trending/2NaDqjDqSrtGxIo9cA5soA2 content esgSubNav
In This List

Blackstone funds to buy Japan's AYUMI Pharmaceutical

Blog

Balance Sheet Strategy in an Unusual Rate Environment

Blog

Investors' Views of the Industry Today & the Outlook for Tomorrow

Podcast

Street Talk | Episode 98: Regulatory scrutiny having cooling effect on community bank M&A

Blog

Insight Weekly: M&A outlook; US community bank margins; green hydrogen players' EU expansion


Blackstone funds to buy Japan's AYUMI Pharmaceutical

Private equity funds managed by Blackstone Group LP agreed to purchase Japanese pharmaceutical company AYUMI Pharmaceutical Corp., marking the firm's first control private equity investment in the country.

The agreement was reached with local private equity firm Unison Capital Inc. and medical information site company M3 Inc.

Terms of the deal, expected to close in the second quarter, were not disclosed.

Bloomberg News earlier reported that Unison was evaluating a potential sale of the anti-rheumatic drug maker for up to US$1 billion.